, 5, 6 neurofilament light (NfL),7, 8 and glial fibrillary acidic protein (GFAP)9, 10 have all been shown to associate with certain AD features, but none can demonstrate the high disease specificity of plasma phosphorylated tau (p‐tau). The gene discussed is MAPT; the disease is Alzheimer disease.